Advanced search
Publication Cover
Molecular and Cellular Biology Volume 21, 2001 - Issue 15
Submit an article Journal homepage
16
Views
71
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The Multisubstrate Adapter Gab1 Regulates Hepatocyte Growth Factor (Scatter Factor)–c-Met Signaling for Cell Survival and DNA Repair

Saijun Fan1 Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York11040
,
Yong Xian Ma1 Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York11040
,
Min Gao1 Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York11040
,
Ren-Qi Yuan1 Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York11040
,
Qinghui Meng1 Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York11040
,
Itzhak D. Goldberg1 Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York11040
&
Eliot M. Rosen1 Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York11040;2 Department of Developmental and Molecular Biology, Hormone-Related Tumor Biology, and Radiation Oncology, Albert Einstein College of Medicine, Bronx, New York10461Correspondence[email protected]
 show all
Pages 4968-4984 | Received 14 Sep 2000, Accepted 30 Apr 2001, Published online: 28 Mar 2023

Citations (71)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xiangdong Liu, Wenqing Yao, Robert C Newton & Peggy A Scherle. (2008) Targeting the c-MET signaling pathway for cancer therapy. Expert Opinion on Investigational Drugs 17:7, pages 997-1011.
Read now
Yingqing Sun, Jing Yuan, Houqi Liu, Zhongqing Shi, Kelly Baker, Kristiina Vuori, Jie Wu & Gen-Sheng Feng. (2004) Role of Gab1 in UV-Induced c-Jun NH2-Terminal Kinase Activation and Cell Apoptosis. Molecular and Cellular Biology 24:4, pages 1531-1539.
Read now

Articles from other publishers (69)

Fatemeh Moosavi, Elisa Giovannetti, Godefridus J. Peters & Omidreza Firuzi. (2021) Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer. Critical Reviews in Oncology/Hematology 160, pages 103234.
Crossref
Bekesho Geleta, Kyung Chan Park, Patric J. Jansson, Sumit Sahni, Sanaz Maleki, Zhihong Xu, Takashi Murakami, Marina Pajic, Minoti V. Apte, Des R. Richardson & Zaklina Kovacevic. (2021) Breaking the cycle: Targeting of NDRG1 to inhibit bi‐directional oncogenic cross‐talk between pancreatic cancer and stroma. The FASEB Journal 35:2.
Crossref
Xin Hua, Zhi-Qing Long, Ling Guo, Wen Wen, Xin Huang, Wen-Wen Zhang & Huan-Xin Lin. (2021) IQGAP3 Overexpression Correlates With Poor Prognosis and Radiation Therapy Resistance in Breast Cancer. Frontiers in Pharmacology 11.
Crossref
Kyung Chan Park, Bekesho Geleta, Lionel Yi Wen Leck, Jasmina Paluncic, Shannon Chiang, Patric J. Jansson, Zaklina Kovacevic & Des R. Richardson. (2020) Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding. Journal of Biological Chemistry 295:2, pages 481-503.
Crossref
Kyle C. Cuneo, Ranjit K. Mehta, Himabindu Kurapati, Dafydd G. Thomas, Theodore S. Lawrence & Mukesh K. Nyati. (2019) Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib. Translational Oncology 12:2, pages 209-216.
Crossref
Eleonora Orlando, Daniel Matthias Aebersold, Michaela Medová & Yitzhak Zimmer. (2019) Oncogene addiction as a foundation of targeted cancer therapy: The paradigm of the MET receptor tyrosine kinase. Cancer Letters 443, pages 189-202.
Crossref
Alexia Hervieu & Stéphanie Kermorgant. (2018) The Role of PI3K in Met Driven Cancer: A Recap. Frontiers in Molecular Biosciences 5.
Crossref
Ina Dervishi, Oge Gozutok, Kevin Murnan, Mukesh Gautam, Daniel Heller, Eileen Bigio & P. Hande Ozdinler. (2018) Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel targets in ALS. Scientific Reports 8:1.
Crossref
Nariyoshi Shinomiya, Qian Xie & George F. Vande Woude. 2018. Regulation of Signal Transduction in Human Cell Research. Regulation of Signal Transduction in Human Cell Research 129 154 .
Giuditta Viticchiè & Patricia Muller. (2015) c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences. Biomedicines 3:1, pages 46-70.
Crossref
Michael S. Rooney, Sachet A. Shukla, Catherine J. Wu, Gad Getz & Nir Hacohen. (2015) Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity. Cell 160:1-2, pages 48-61.
Crossref
ChongFeng Gao & George F. Vande Woude. 2015. Receptor Tyrosine Kinases: Family and Subfamilies. Receptor Tyrosine Kinases: Family and Subfamilies 321 358 .
Maria Prat, Francesca Oltolina & Cristina Basilico. (2014) Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy. Biomedicines 2:4, pages 359-383.
Crossref
Ahmed J. Awad, Terry C. Burns, Ying Zhang & Roger Abounader. (2014) Targeting MET for glioma therapy. Neurosurgical Focus 37:6, pages E10.
Crossref
Yingqiu XieWenfu LuShenji LiuQing YangBrett S. CarverEstelle Li, Yuzhuo Wang, Ladan Fazli, Martin Gleave & Zhenbang Chen. (2014) Crosstalk Between Nuclear MET and SOX9/β-Catenin Correlates with Castration-Resistant Prostate Cancer. Molecular Endocrinology 28:10, pages 1629-1639.
Crossref
Shoko Kumazawa, Hiroaki Kajiyama, Tomokazu Umezu, Mika Mizuno, Shiro Suzuki, Eiko Yamamoto, Hiroko Mitsui, Ryuichiro Sekiya, Kiyosumi Shibata & Fumitaka Kikkawa. (2014) Possible association between stem-like hallmark and radioresistance in human cervical carcinoma cells. Journal of Obstetrics and Gynaecology Research 40:5, pages 1389-1398.
Crossref
Michaela Medová, Daniel Aebersold & Yitzhak Zimmer. (2013) The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response—Biological and Clinical Aspects. Cancers 6:1, pages 1-27.
Crossref
VASU TUMATI, SUBASHRI KUMAR, LAN YU, BENJAMIN CHEN, HAK CHOY & DEBABRATA SAHA. (2013) Effect of PF-02341066 and radiation on non-small cell lung cancer cells. Oncology Reports 29:3, pages 1094-1100.
Crossref
Cyrus Chargari, Céline Clemenson, Isabelle Martins, Jean-Luc Perfettini & Eric Deutsch. (2013) Understanding the functions of tumor stroma in resistance to ionizing radiation: Emerging targets for pharmacological modulation. Drug Resistance Updates 16:1-2, pages 10-21.
Crossref
Yun Peng, Matthew Huentelman, Christopher Smith & Shenfeng Qiu. 2013. Neurobiology of Autism. Neurobiology of Autism 135 165 .
Carine Joffre, Rachel Barrow, Ludovic Ménard & Stéphanie Kermorgant. 2013. Vesicle Trafficking in Cancer. Vesicle Trafficking in Cancer 261 277 .
Arnaud Le Goff, Zongling Ji, Bérénice Leclercq, Roland P. Bourette, Alexandra Mougel, Cateline Guerardel, Yvan de Launoit, Jérôme Vicogne, Gautier Goormachtigh & Véronique Fafeur. (2012) Anti-apoptotic Role of Caspase-cleaved GAB1 Adaptor Protein in Hepatocyte Growth Factor/Scatter Factor-MET Receptor Protein Signaling. Journal of Biological Chemistry 287:42, pages 35382-35396.
Crossref
Vikas Bhardwaj, Yanai Zhan, Maria Angelica Cortez, Kie Kian Ang, David Molkentine, Anupama Munshi, Uma Raju, Ritsuko Komaki, John V. Heymach & James Welsh. (2012) C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non–Small-Cell Lung Cancer Cells With Radiation-Induced c-Met–Expression. Journal of Thoracic Oncology 7:8, pages 1211-1217.
Crossref
Lu Xu, Eiki Kikuchi, Chunxiao Xu, Hiromichi Ebi, Dalia Ercan, Katherine A. Cheng, Robert Padera, Jeffrey A. Engelman, Pasi A. Jänne, Geoffrey I. Shapiro, Takeshi Shimamura & Kwok-Kin Wong. (2012) Combined EGFR/MET or EGFR/HSP90 Inhibition Is Effective in the Treatment of Lung Cancers Codriven by Mutant EGFR Containing T790M and MET. Cancer Research 72:13, pages 3302-3311.
Crossref
M Acunzo, R Visone, G Romano, A Veronese, F Lovat, D Palmieri, A Bottoni, M Garofalo, P Gasparini, G Condorelli, M Chiariello & C M Croce. (2011) miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 31:5, pages 634-642.
Crossref
Daniel W. Fults. 2012. Pediatric Cancer, Volume 3. Pediatric Cancer, Volume 3 93 101 .
Christopher D Lindsay. (2010) Novel therapeutic strategies for acute lung injury induced by lung damaging agents: The potential role of growth factors as treatment options. Human & Experimental Toxicology 30:7, pages 701-724.
Crossref
Ronald Allan M Panganiban & Regina M Day. (2010) Hepatocyte growth factor in lung repair and pulmonary fibrosis. Acta Pharmacologica Sinica 32:1, pages 12-20.
Crossref
Zhong Chen. 2011. Signaling Pathways in Squamous Cancer. Signaling Pathways in Squamous Cancer 91 111 .
Hyun-Ja Nam, Sunyoung Chae, Seung-Hoon Jang, Hyeseong Cho & Jae-Ho Lee. (2010) The PI3K–Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability. Carcinogenesis 31:9, pages 1531-1540.
Crossref
Saijun Fan, Qinghui Meng, John J. Laterra & Eliot M. Rosen. (2010) Scatter factor protects tumor cells against apoptosis caused by TRAIL. Anti-Cancer Drugs 21:1, pages 10-24.
Crossref
Davide M. Ferraris, Ermanno Gherardi, Ying Di, Dirk W. Heinz & Hartmut H. Niemann. (2010) Ligand-Mediated Dimerization of the Met Receptor Tyrosine Kinase by the Bacterial Invasion Protein InlB. Journal of Molecular Biology 395:3, pages 522-532.
Crossref
Shin Yasuda, Hiroko Sugiura & Kanato Yamagata. (2009) Mek3. AfCS-Nature Molecule Pages.
Crossref
James W Welsh, Daruka Mahadevan, Ron Ellsworth, Laurence Cooke, David Bearss & Baldassarre Stea. (2009) The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells. Radiation Oncology 4:1.
Crossref
Hal E Crosswell, Anindya Dasgupta, Carlos S Alvarado, Tanya Watt, James G Christensen, Pradip De, Donald L Durden & Harry W Findley. (2009) PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells. BMC Cancer 9:1.
Crossref
Saijun Fan, Qinghui Meng, John J. Laterra & Eliot M. Rosen. (2009) Role of Src Signal Transduction Pathways in Scatter Factor-mediated Cellular Protection. Journal of Biological Chemistry 284:12, pages 7561-7577.
Crossref
Roger Abounader & John Laterra. 2009. CNS Cancer. CNS Cancer 933 952 .
Zhong Chen, Reza Ehsanian & Carter Van Waes. 2010. Oral Cancer Metastasis. Oral Cancer Metastasis 197 229 .
Chol Seung Lim & Randall S. Walikonis. (2008) Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. Cellular Signalling 20:5, pages 825-835.
Crossref
D Tulasne & B Foveau. (2007) The shadow of death on the MET tyrosine kinase receptor. Cell Death & Differentiation 15:3, pages 427-434.
Crossref
F Foijer, M Simonis, M van Vliet, L Wessels, R Kerkhoven, P K Sorger & H te Riele. (2007) Oncogenic pathways impinging on the G2-restriction point. Oncogene 27:8, pages 1142-1154.
Crossref
Ziqiu Wang, Lisheng Ge, Meifang Wang & Brian I. Carr. (2007) Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5. Hepatology 46:6, pages 2003-2013.
Crossref
S Fan, Q Meng, J J Laterra & E M Rosen. (2007) Ras effector pathways modulate scatter factor-stimulated NF-κB signaling and protection against DNA damage. Oncogene 26:33, pages 4774-4796.
Crossref
Yang JIAO, Chun-min GE, Qing-hui MENG, Jian-ping CAO, Jian TONG & Sai-jun FAN. (2007) Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacologica Sinica 28:7, pages 1045-1056.
Crossref
J Xu, M Gao, S Fan, Q Meng, I D Goldberg, R Abounader, H Ressom, J J Laterra & E M Rosen. (2006) Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. Oncogene 26:20, pages 2925-2938.
Crossref
Keiji Furuuchi, Alan Berezov, Toru Kumagai & Mark I. Greene. (2007) Targeted Antireceptor Therapy with Monoclonal Antibodies Leads to the Formation of Inactivated Tetrameric Forms of ErbB Receptors. The Journal of Immunology 178:2, pages 1021-1029.
Crossref
Christian Parr & Wen G. Jiang. 2007. Metastasis of Breast Cancer. Metastasis of Breast Cancer 171 202 .
Gregory A. Watson, Xinglu Zhang, Michael T. Stang, Ryan M. Levy, Pierre E. Queiroz de Oliveira, William E. Gooding, James G. Christensen & Steven J. Hughes. (2006) Inhibition of c-Met as a Therapeutic Strategy for Esophageal Adenocarcinoma. Neoplasia 8:11, pages 949-955.
Crossref
Michela Fassetta, Lorenza D'Alessandro, Nadia Coltella, Maria Flavia Di Renzo & Andrea Rasola. (2006) Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis. Cellular Signalling 18:11, pages 1967-1976.
Crossref
Yongxian Ma, Ren-qi Yuan, Saijun Fan, Changyan Hu, Itzhak D. Goldberg, John J. Laterra & Eliot M. Rosen. (2006) Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum. Anti-Cancer Drugs 17:7, pages 733-751.
Crossref
Marie Dance, Alexandra Montagner, Armelle Yart, Bernard Masri, Yves Audigier, Bertrand Perret, Jean-Pierre Salles & Patrick Raynal. (2006) The Adaptor Protein Gab1 Couples the Stimulation of Vascular Endothelial Growth Factor Receptor-2 to the Activation of Phosphoinositide 3-Kinase. Journal of Biological Chemistry 281:32, pages 23285-23295.
Crossref
Saijun Fan, Min Gao, Qinghui Meng, John J Laterra, Marc H Symons, Sal Coniglio, Richard G Pestell, Itzhak D Goldberg & Eliot M Rosen. (2005) Role of NF-κB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24:10, pages 1749-1766.
Crossref
Wen G. Jiang, Tracey A. Martin, Christian Parr, Gaynor Davies, Kunio Matsumoto & Toshikazu Nakamura. (2005) Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Critical Reviews in Oncology/Hematology 53:1, pages 35-69.
Crossref
Yong Wei & Jessie L.-S. Au. 2005. Integration/Interaction of Oncologic Growth. Integration/Interaction of Oncologic Growth 285 321 .
Nariyoshi Shinomiya, Chong Feng Gao, Qian Xie, Margaret Gustafson, David J. Waters, Yu-Wen Zhang & George F. Vande Woude. (2004) RNA Interference Reveals that Ligand-Independent Met Activity Is Required for Tumor Cell Signaling and Survival. Cancer Research 64:21, pages 7962-7970.
Crossref
Nilanjana Maulik & Gautam Maulik. 2004. Phytopharmaceuticals in Cancer Chemoprevention. Phytopharmaceuticals in Cancer Chemoprevention.
Anders Kallin, Jean-Baptiste Demoulin, Keigo Nishida, Toshio Hirano, Lars Rönnstrand & Carl-Henrik Heldin. (2004) Gab1 Contributes to Cytoskeletal Reorganization and Chemotaxis in Response to Platelet-derived Growth Factor. Journal of Biological Chemistry 279:17, pages 17897-17904.
Crossref
Marina Holgado-Madruga & Albert J. Wong. (2004) Role of the Grb2-Associated Binder 1/SHP-2 Interaction in Cell Growth and Transformation. Cancer Research 64:6, pages 2007-2015.
Crossref
Andrea Rasola, Sergio Anguissola, Norma Ferrero, Daniela Gramaglia, Antonella Maffe, Piera Maggiora, Paolo M. Comoglio & M. Flavia Di Renzo. (2004) Hepatocyte Growth Factor Sensitizes Human Ovarian Carcinoma Cell Lines to Paclitaxel and Cisplatin. Cancer Research 64:5, pages 1744-1750.
Crossref
Kenji Takeuchi & Fumiaki Ito. (2004) Suppression of Adriamycin-induced Apoptosis by Sustained Activation of the Phosphatidylinositol-3′-OH kinase-Akt Pathway. Journal of Biological Chemistry 279:2, pages 892-900.
Crossref
Carmen Birchmeier, Walter Birchmeier, Ermanno Gherardi & George F. Vande Woude. (2003) Met, metastasis, motility and more. Nature Reviews Molecular Cell Biology 4:12, pages 915-925.
Crossref
Madhulika DixitDaming ZhuangBogdan CeacareanuAviv Hassid. (2003) Treatment With Insulin Uncovers the Motogenic Capacity of Nitric Oxide in Aortic Smooth Muscle Cells. Circulation Research 93:10.
Crossref
Lorenza Tacchini, Emanuela Matteucci, Cristina De Ponti & Maria Alfonsina Desiderio. (2003) Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1. Experimental Cell Research 290:2, pages 391-401.
Crossref
Chunmei Zhao, Hong Ma, Ella Bossy-Wetzel, Stuart A. Lipton, Zhuohua Zhang & Gen-Sheng Feng. (2003) GC-GAP, a Rho Family GTPase-activating Protein That Interacts with Signaling Adapters Gab1 and Gab2. Journal of Biological Chemistry 278:36, pages 34641-34653.
Crossref
Emanuela Matteucci, Silvia Modora, Matteo Simone & Maria Alfonsina Desiderio. (2004) Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiency. Oncogene 22:26, pages 4062-4073.
Crossref
M Ozaki, S Haga, H Q Zhang, K Irani & S Suzuki. (2003) Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death & Differentiation 10:5, pages 508-515.
Crossref
P W B Derksen, D J J de Gorter, H P Meijer, R J Bende, M van Dijk, H M Lokhorst, A C Bloem, M Spaargaren & S T Pals. (2003) The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma. Leukemia 17:4, pages 764-774.
Crossref
Cheng Fang Yu, Zhen-Xiang Liu & Lloyd G. Cantley. (2002) ERK Negatively Regulates the Epidermal Growth Factor-mediated Interaction of Gab1 and the Phosphatidylinositol 3-Kinase. Journal of Biological Chemistry 277:22, pages 19382-19388.
Crossref
Min Gao, Saijun Fan, Itzhak D. Goldberg, John Laterra, Richard N. Kitsis & Eliot M. Rosen. (2001) Hepatocyte Growth Factor/Scatter Factor Blocks the Mitochondrial Pathway of Apoptosis Signaling in Breast Cancer Cells. Journal of Biological Chemistry 276:50, pages 47257-47265.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.